Evidence map›Paper›PMID 24118836›Full record

ArticleTraffic (Copenhagen, Denmark)2014

Targeted disruption of an EH-domain protein endocytic complex, Pan1-End3.

Karen Whitworth, Mary Katherine Bradford, Nicole Camara, Beverly Wendland

Abstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Candida albicansMicrobiology spectrum · 2022
    Article
  3. Candida albicansmSphere · 2021
    Article
  4. The Role of Secretory Pathways inJournal of fungi (Basel, Switzerland) · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karen WhitworthDepartment of Biology, The Johns Hopkins University, Baltimore, MD, 21218, USA.
Mary Katherine Bradford
Nicole Camara
Beverly Wendland
Johns Hopkins University · US

Funding

CELLULAR AND MOLECULAR BIOLOGYT32GM007231 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VAN DOREN, MARK B · 1985 to 2020
$18.4M
MOLECULAR ANALYSIS OF ENDOCYTOSIS PROTEINS IN YEASTR01GM060979 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI WENDLAND, BEVERLY R · 2000 to 2013
$4.3M
NIGMS NIH HHS R01 GM060979NIGMS NIH HHS R01 GM60979NIGMS NIH HHS T32 GM007231PHS HHS T32 007231-37
6 · The paper itself

Abstract

Pan1 is a multi-domain scaffold that enables dynamic interactions with both structural and regulatory components of the endocytic pathway. Pan1 is composed of Eps15 Homology (EH) domains which interact with adaptor proteins, a central region that is responsible for its oligomerization and C-terminal binding sites for Arp2/3, F-actin, and type-I myosin motors. In this study, we have characterized the binding sites between Pan1 and its constitutive binding partner End3, another EH domain containing endocytic protein. The C-terminal End3 Repeats of End3 associate with the N-terminal part of Pan1's central coiled-coil region. These repeats appear to act independently of one another as tandem, redundant binding sites for Pan1. The end3-1 allele was sequenced, and corresponds to a C-terminal truncation lacking the End3 Repeats. Mutations of the End3 Repeats highlight that those residues which are identical between these repeats serve as contact sites for the interaction with Pan1.

Indexed as

EndocytosisAmino Acid MotifsAmino Acid SequenceBinding SitesCytoskeletal ProteinsMicrofilament ProteinsMolecular Sequence DataMutationProtein BindingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCytoskeletal ProteinsEND3 protein, S cerevisiaeMicrofilament ProteinsPAN1 protein, S cerevisiaeSaccharomyces cerevisiae Proteinsamphipathic helixEH domainEnd3End3-1endocytosisPan1

Identifiers

PMID24118836
PMCPMC3855908
OpenAlexW1767007164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.